FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123383121> ?p ?o ?g. }

• W2123383121 endingPage "9518" @default.
• W2123383121 startingPage "9512" @default.
• W2123383121 abstract "Abstract The prevalence of metabolic syndrome is increasing along with breast cancer incidence worldwide. Because fenretinide improves insulin action and glucose tolerance in insulin-resistant obese mice and because tamoxifen has shown to regulate several markers involved in metabolic syndrome, we sought to investigate the effect of fenretinide or tamoxifen at low dose on features linked to insulin resistance in premenopausal women at risk for breast cancer. We randomized 235 women to low-dose tamoxifen (5 mg/daily), fenretinide (200 mg/daily), or their combination or placebo for 2 years. We used the homeostasis model assessment (HOMA; fasting insulin × glucose/22.5) to estimate insulin sensitivity. Women were considered to improve insulin sensitivity when they shifted from a HOMA ≥2.8 to &lt;2.8. There was no effect of fenretinide or tamoxifen on HOMA overall, but overweight women (body mass index, ≥25 kg/m2) had a 7-fold greater probability to normalize HOMA after 2 years of fenretinide treatment [odds ratio (OR), 7.0; 95% confidence interval (95% CI), 1.2–40.5], with 25% of women improving their insulin sensitivity, whereas tamoxifen decreased insulin sensitivity by almost 7 times compared with subjects not taking tamoxifen (OR, 0.15; 95% CI, 0.03–0.88). In this group only, 5% improved their insulin sensitivity. Interestingly, women with intraepithelial or microinvasive neoplasia had higher HOMA (3.0) than unaffected subjects (2.8; P = 0.07). Fenretinide can positively balance the metabolic profile in overweight premenopausal women and this may favorably affect breast cancer risk. Furthermore, features of the metabolic syndrome should be taken into consideration before proposing tamoxifen for breast cancer prevention. The clinical implications of these results require further investigations. [Cancer Res 2008;68(22):9512–8]" @default.
• W2123383121 created "2016-06-24" @default.
• W2123383121 creator A5015077519 @default.
• W2123383121 creator A5022387451 @default.
• W2123383121 creator A5035474342 @default.
• W2123383121 creator A5035649007 @default.
• W2123383121 creator A5040377654 @default.
• W2123383121 creator A5046547806 @default.
• W2123383121 creator A5055344568 @default.
• W2123383121 creator A5062416354 @default.
• W2123383121 creator A5075772633 @default.
• W2123383121 creator A5079114893 @default.
• W2123383121 date "2008-11-14" @default.
• W2123383121 modified "2023-10-13" @default.
• W2123383121 title "Effect of Fenretinide and Low-Dose Tamoxifen on Insulin Sensitivity in Premenopausal Women at High Risk for Breast Cancer" @default.
• W2123383121 cites W1894178646 @default.
• W2123383121 cites W1948079440 @default.
• W2123383121 cites W1968094237 @default.
• W2123383121 cites W1969426577 @default.
• W2123383121 cites W1970607638 @default.
• W2123383121 cites W1971255955 @default.
• W2123383121 cites W1979030077 @default.
• W2123383121 cites W1988723877 @default.
• W2123383121 cites W1996639471 @default.
• W2123383121 cites W2003813199 @default.
• W2123383121 cites W2005889403 @default.
• W2123383121 cites W2015875153 @default.
• W2123383121 cites W2026880258 @default.
• W2123383121 cites W2041281080 @default.
• W2123383121 cites W2042692634 @default.
• W2123383121 cites W2047729518 @default.
• W2123383121 cites W2060215552 @default.
• W2123383121 cites W2060824741 @default.
• W2123383121 cites W2061975232 @default.
• W2123383121 cites W2068915367 @default.
• W2123383121 cites W2080886948 @default.
• W2123383121 cites W2085416815 @default.
• W2123383121 cites W2088652321 @default.
• W2123383121 cites W2092136583 @default.
• W2123383121 cites W2111417767 @default.
• W2123383121 cites W2112025328 @default.
• W2123383121 cites W2115375080 @default.
• W2123383121 cites W2121065118 @default.
• W2123383121 cites W2125805218 @default.
• W2123383121 cites W2129731670 @default.
• W2123383121 cites W2133185366 @default.
• W2123383121 cites W2134393064 @default.
• W2123383121 cites W2140002069 @default.
• W2123383121 cites W2141647078 @default.
• W2123383121 cites W2146569020 @default.
• W2123383121 cites W2149317429 @default.
• W2123383121 cites W2151496733 @default.
• W2123383121 cites W2157226695 @default.
• W2123383121 cites W2160234571 @default.
• W2123383121 cites W2162255983 @default.
• W2123383121 cites W2165845535 @default.
• W2123383121 cites W2167543957 @default.
• W2123383121 cites W2167599338 @default.
• W2123383121 cites W2240483938 @default.
• W2123383121 cites W2414290242 @default.
• W2123383121 cites W3148261934 @default.
• W2123383121 doi "https://doi.org/10.1158/0008-5472.can-08-0553" @default.
• W2123383121 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2599903" @default.
• W2123383121 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19010927" @default.
• W2123383121 hasPublicationYear "2008" @default.
• W2123383121 type Work @default.
• W2123383121 sameAs 2123383121 @default.
• W2123383121 citedByCount "70" @default.
• W2123383121 countsByYear W21233831212012 @default.
• W2123383121 countsByYear W21233831212013 @default.
• W2123383121 countsByYear W21233831212014 @default.
• W2123383121 countsByYear W21233831212015 @default.
• W2123383121 countsByYear W21233831212016 @default.
• W2123383121 countsByYear W21233831212017 @default.
• W2123383121 countsByYear W21233831212018 @default.
• W2123383121 countsByYear W21233831212019 @default.
• W2123383121 countsByYear W21233831212020 @default.
• W2123383121 countsByYear W21233831212021 @default.
• W2123383121 countsByYear W21233831212022 @default.
• W2123383121 countsByYear W21233831212023 @default.
• W2123383121 crossrefType "journal-article" @default.
• W2123383121 hasAuthorship W2123383121A5015077519 @default.
• W2123383121 hasAuthorship W2123383121A5022387451 @default.
• W2123383121 hasAuthorship W2123383121A5035474342 @default.
• W2123383121 hasAuthorship W2123383121A5035649007 @default.
• W2123383121 hasAuthorship W2123383121A5040377654 @default.
• W2123383121 hasAuthorship W2123383121A5046547806 @default.
• W2123383121 hasAuthorship W2123383121A5055344568 @default.
• W2123383121 hasAuthorship W2123383121A5062416354 @default.
• W2123383121 hasAuthorship W2123383121A5075772633 @default.
• W2123383121 hasAuthorship W2123383121A5079114893 @default.
• W2123383121 hasBestOaLocation W21233831211 @default.
• W2123383121 hasConcept C104317684 @default.
• W2123383121 hasConcept C121608353 @default.
• W2123383121 hasConcept C126322002 @default.
• W2123383121 hasConcept C134018914 @default.
• W2123383121 hasConcept C143998085 @default.
• W2123383121 hasConcept C2775954498 @default.

• next